Lab Reactor Designed for Scale-up
PTSM: Pharmaceutical Technology Sourcing and Management
The ReactoMate Datum controlled lab reactor system accommodates a range of vessel sizes.
The ReactoMate Datum, a universal benchtop controlled lab reactor (CLR) from Asynt designed to aid synthesis scale-up, accommodates vessels from 100 ml to 5 L. The device is constructed from anodized aluminum and stainless steel, and operates in temperatures spanning -70 ºC to +220 ºC.
The ReactoMate Datum fits into a standard lab fume hood and is compatible with multiple brands of overhead stirrers and circulator heating/cooling systems. The CLR’s temperature probe is linked to the heating/cooling circulator and manages solution temperature control.
Reaction vessels can be exchanged, allowing chemists to change between reactor vessel sizes, enabling synthesis scale-up.
Source: Asynt Ltd.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
